Prospective trials comparing clinical outcomes of occasionally screened low-risk women with outcomes of low-risk women screened annually may overlook or misidentify breast cancers that exist but haven’t advanced, according to a new editorial. 

Carestream Health will demonstrate its Touch Ultrasound platform that offers features designed to address current challenges in sonography at the Society of Diagnostic Medical Sonography (SDMS) conference and exhibit that begins Oct. 1 in Dallas, Texas.

Edinburgh Molecular Imaging Ltd. (EM Imaging) has signed an exclusive global license for a novel optical imaging agent that could improve the detection of early-stage colorectal (bowel) cancer.

Siemens Healthcare has announced that the FDA cleared the company’s latest full-field digital mammography system, the Mammomat Fusion.

Has overuse of mammography created an epidemic of breast cancer pseudo-survivorship? That was the provocative question asked in a recent editorial published by Forbes.

A $2.5 million grant from the National Institutes of Health/National Cancer Institute will be given to the University of Oklahoma (OU) and Mercy Hospital Oklahoma City to go toward the development of new short-term breast cancer risk prediction models.

Who doesn’t like getting things for free? It’s even better when the freebies are used to incentivize patients to quit smoking or eat healthy. But should those gift cards, event tickets and t-shirts be used to get women to come in for a mammogram?

Research has once again shown that false-positive screening mammography results lead to increased anxiety for the women that receive them, and that these feelings can last for months. But how much should we fear the fear itself?